Emad Elkadi

Emad Elkadi has extensive work experience in the pharmaceutical industry. Emad is currently serving as the Market Access & Pricing Head - MEA at Stemline Therapeutics since February 2022.

Prior to that, Emad worked at Takeda for several years, holding various roles. Emad served as the Head of Patient Value Access - ICMEA from August 2020 to November 2021. Before that, they were the Head of Access to Medicine & Patient Service - ICMEA for India, CIS, Middle East, Turkey, and Africa from April 2019 to July 2020. Emad also served as the Director Market Access MENA for the Middle East & North Africa from April 2018 to March 2019, and as the Director Market Access & Business Insights for Saudi Arabia from November 2016 to March 2018. Prior to those roles, they were the Market Access & Business Insights Associate Director – Middle East from April 2015 to October 2016 and the Market Access Lead - Middle East from November 2013 to March 2015.

Emad also gained experience at other pharmaceutical companies. Emad worked at Merck as a Market Access Lead from January 2011 to October 2013 and as a Customer Manager, Immunology from January 2010 to December 2010. Before that, they worked at Schering-Plough as a Regional Sales Manager, Primary Health Care from March 2008 to December 2009, as a Key Account Manager, Primary Health Care from March 2007 to February 2008, and as a Medical Representative from April 2001 to February 2007. Emad began their career at SHS International as a Product Specialist from June 2000 to March 2001 and at Novartis as a Medical Representative from January 1999 to May 2000.

Emad Elkadi obtained their Bachelor's degree in pharmaceutical science from the Faculty of Pharmacy at Alexandria University in Egypt. Emad pursued further education and earned an MBA degree in general studies from the Arab Academy for Science, Technology and Maritime Transport.